B-lymphoblastic leukemia/lymphoma with BCR::ABL1 fusion has also been reported to exhibit a decreased expression of CD9 and CD81 when compared with cases of B-lymphoblastic leukemia/lymphoma without cytogenetic alterations or with other cytogenetic abnormalities [11]. This evidence concerns the gene ABL1 and lymphoma.